SHIFT AI Newsroom · GLOBAL

Orforglipron Being Investigated for Obesity-Related Complications

A clinical trial is underway to study the effects of Orforglipron in participants with overweight at risk of developing obesity-related complications.

Published 2026-09-10 · Evidence level 2

A clinical trial is underway to investigate the use of Orforglipron in participants with overweight at risk of developing obesity-related complications. The trial is registered on ClinicalTrials.gov and is currently in the clinical trial stage.

What this means in the UK

This trial may potentially lead to new treatment options for individuals in the UK who are at risk of developing obesity-related complications.

Known facts

  • A clinical trial is underway to study the effects of Orforglipron in participants with overweight at risk of developing obesity-related complications.

Sources and evidence

← Back to SHIFT AI Newsroom